

The COVID-19 pandemic has disrupted many aspects of life on a global scale. As disruptions often do, it also has accelerated the implementation of solutions that might otherwise still be waiting their turn as future 'nice-to-haves.' In 2020, digital transformation of customer engagement was accelerated across the industry, and we expect this to continue in 2021.
For some pharmaceutical companies, the path toward multi-channel customer engagement has meant pushing more teams to adopt existing remote tools or switching from face-to-face to virtual meetings. For others, the transformation has spurred providers to create capabilities from scratch. For a few, this time has presented an opportunity to make leaps previously considered experimental.
In this webinar series, Connecting to the Future of Customer Engagement, we will share what we have learned from the adaptations made by those leading the industry and discuss the most significant trends, particularly connected intelligence, local leader influence, patient community management, and incremental improvements for agility.
António Pregueiro
VP Life Science and Practice Lead, IQVIA